Article makes simple errors and could cause unnecessary deaths [1]

British Medical Journal

Volumn 324, Issue 7330, 2002, Pages 167-

  Baigent, Colin ^a   Collins, Rory ^a   Peto, Richard ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ARTICLE; CLINICAL TRIAL; DEATH; HEART INFARCTION; HUMAN; LETTER; MEDICAL LITERATURE; MORTALITY; PRIORITY JOURNAL;

ASPIRIN; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; HUMANS; META-ANALYSIS; PLATELET AGGREGATION INHIBITORS; RESEARCH DESIGN;

EID: 0037132804     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients
2. For debate: Preventing atherosclerotic events with aspirin
3. No reduction in cardiovascular risk with NSAlDS - Including aspirin?
4. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction
5. ISIS-2: 10-Year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither
6. Secondary prevention of vascular disease by prolonged antiplatelet treatment
7. Long-term ACE-inhibitor therapy in patients with heart failure or left ventricular dysfunction: A systematic overview of data from individual patients